Subsidy Information and Financing Scheme MAFVedolizumab (Entyvio) Infusion 300 mg Additional clinical criteria applies Treatment of adults with moderately to severely active Crohn’... See all × MAFVedolizumab (Entyvio) Infusion 300 mg Additional clinical criteria applies Treatment of adults with moderately to severely active Crohn’s disease who have failed both conventional therapy and anti-TNFα biologics.
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Entyvio Infusion 300 mg Changi General Hospital Khoo Teck Puat Hospital National University Hospital Singapore General Hospital Tan Tock Seng Hospital